An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA.
about
P1343
TORC2, a coactivator of cAMP-response element-binding protein, promotes Epstein-Barr virus reactivation from latency through interaction with viral BZLF1 proteinOncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line AkataEpstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expressionEpstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replicationT cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma linesEpstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis.The Role of Gammaherpesviruses in Cancer PathogenesisCo-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesisProtein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins.Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cellsBS69/ZMYND11 C-Terminal Domains Bind and Inhibit EBNA2.Modulation of Epstein-Barr virus nuclear antigen 2-dependent transcription by protein arginine methyltransferase 5.Oncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: In vitro and in vivo studies.Epstein-Barr virus provides a survival factor to Burkitt's lymphomas.Induction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivoEpstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infectRedefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell linesThe Epstein-Barr virus (EBV) SM protein enhances pre-mRNA processing of the EBV DNA polymerase transcript.Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway.Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus.Epstein-Barr virus that lacks glycoprotein gN is impaired in assembly and infectionA viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirusEither ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.Activation and repression of Epstein-Barr Virus and Kaposi's sarcoma-associated herpesvirus lytic cycles by short- and medium-chain fatty acidsId1 interacts and stabilizes the Epstein-Barr virus latent membrane protein 1 (LMP1) in nasopharyngeal epithelial cells.The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cellsUnexpected instability of family of repeats (FR), the critical cis-acting sequence required for EBV latent infection, in EBV-BAC systems.Latent Epstein-Barr virus can inhibit apoptosis in B cells by blocking the induction of NOXA expressionMapping the N-terminal residues of Epstein-Barr virus gp42 that bind gH/gL by using fluorescence polarization and cell-based fusion assaysCellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells.Virus and cell RNAs expressed during Epstein-Barr virus replicationComprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells.CD137 expression is induced by Epstein-Barr virus infection through LMP1 in T or NK cells and mediates survival promoting signals.Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.BGLF4 kinase modulates the structure and transport preference of the nuclear pore complex to facilitate nuclear import of Epstein-Barr virus lytic proteinsMicroarray identifies ADAM family members as key responders to TGF-beta1 in alveolar epithelial cellsEnhanced susceptibility of B lymphoma cells to measles virus by Epstein-Barr virus type III latency that upregulates CD150/signaling lymphocytic activation molecule.Pan-viral-microRNA screening identifies interferon inhibition as a common function of diverse viruses.Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene.
P2860
Q24320081-11315319-8165-4D1E-95E6-1B391923B7A3Q24527320-56193F59-8DA5-47A4-9836-1981A58E243FQ24562972-8C3702B0-C2C5-4DE5-B3A6-66AFC40455F6Q24671870-55986BC6-7B1C-40D8-9EF8-2C368AB27071Q24681203-3C140B09-1C9B-48DF-97D8-026BE93DBA91Q24816875-F40953F1-3FBD-493A-BA53-A6C24B7432BDQ26767186-FACCBC65-70AF-4F52-8705-8AF45DED41FBQ28077209-A924A50D-76D6-49B9-9C54-C18E6D68946AQ28114910-1E92A400-DF6D-48C6-9379-2AD82833CAA3Q28484266-B70A4085-5C65-4708-8148-72AB8CB81771Q30981859-67483AB8-A922-4632-A11B-660F4BF531BAQ33601328-7B09B815-2399-4D7F-98FD-70A1C4D3F6E0Q33713735-2A11C5E8-A250-4D5F-8C7C-FB7B7F3D7700Q33716529-99B9121B-1E08-4C90-9C0F-86FE5E82C8DEQ33755168-B862BAEC-C84A-44C2-9C54-FB058F677CE5Q33781911-8E6AA43C-42D1-47AD-96D0-ACD6CD2D9DCCQ33784685-974ACE81-A79E-40FD-BCC2-9785BA608833Q33785161-94FCB486-40EC-4B12-ACDD-3B7CB6483034Q33787396-47972211-A7B4-4716-A72D-E442F9C76A7CQ33813615-82141C25-3F08-4F60-AF4B-73E726E1A2B7Q33826978-107EF923-16CC-44D3-B0FA-77CA6510001CQ33838266-32A18F35-DF8C-483D-8B81-CA9227BBCC1DQ33877497-73E84F15-81F1-4212-AB52-F1BDB73417A5Q33900360-6253FA3F-684B-45DE-84FA-76B77918A097Q33942005-6CE23FFF-2F4B-40C3-953A-F4E89F85A029Q34034925-524677D8-D762-460B-8FD5-40FCACB1E99DQ34082799-D7218979-F55C-4CE7-B4E4-047F01E5043EQ34103135-B79012FC-9933-40D7-AF77-23F50A6DF4E0Q34120826-6B3FBAAF-9936-416D-AB45-EDC5CEDDE44BQ34120915-0B017554-361B-4FEC-A814-4CB04B896BC8Q34161866-27D999FD-0CB2-492E-9599-7583557CFECDQ34434702-F9EC2727-4653-4D25-8BBA-36794B34D5F7Q34507851-F17DDF68-829B-42A4-B134-9A8F620066C5Q34542208-A1284CE3-5767-44BF-A455-DF17B76CD88EQ34650591-6640C92E-4692-4EB7-9231-85D90192AD3BQ34991450-60BB75F7-9705-4F37-ABE5-F959B2363027Q35038917-EACF588C-B32D-4A1E-A8A2-5DA7121BAF3FQ35051487-65BBA1F4-6016-4429-B542-419832DED06DQ35089995-CC0AA9CF-7213-461B-9136-53AF32DC283EQ35140290-6EE2A5F4-5CB0-4D3C-BBAA-912EB06A0ABC
P2860
An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
An Epstein-Barr virus-producer ...... ine and analysis of viral DNA.
@en
type
label
An Epstein-Barr virus-producer ...... ine and analysis of viral DNA.
@en
prefLabel
An Epstein-Barr virus-producer ...... ine and analysis of viral DNA.
@en
P2093
P356
P1433
P1476
An Epstein-Barr virus-producer ...... ine and analysis of viral DNA.
@en
P2093
K Horinouchi
M Takahashi
S Hayasaka
P2888
P304
P356
10.1007/BF00571929
P4510
P577
1991-04-01T00:00:00Z
P6179
1006563690